Effect of Different Color Lights on the Internal Clock and Alertness in Humans

计划入组 68 人 · 首次发布于 2022 年 6 月 21 日

24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome

计划入组 80 人 · 首次发布于 2025 年 12 月 18 日

A 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome

计划入组 80 人 · 首次发布于 2026 年 7 月 17 日

FOV 2501

KCNV2 CRISPR/Cas9 gene therapy (AAV, cone dystrophy)

photoreceptor rescue cell therapy

The Moses H. Cone Memorial Hospital Operating Corporation

United States

Si-Bone

United States

Bone Biologics

SparingVision Completes Dosing in Phase I/II Trial for Gene-Agnostic Retinitis Pigmentosa Therapy SPVN06

SparingVision Initiates First-in-Human Trial of Gene-Agnostic Therapy SPVN20 for Advanced Retinitis Pigmentosa

jCyte Initiates Phase 2 Trial of Famzeretcel Cell Therapy for Retinitis Pigmentosa